Literature DB >> 20800636

Effect of MTII on food intake and brain c-Fos in melanocortin-3, melanocortin-4, and double MC3 and MC4 receptor knockout mice.

Neil E Rowland1, Jay W Schaub, Kimberly L Robertson, Amy Andreasen, Carrie Haskell-Luevano.   

Abstract

Mice with genomic knockout of either melanocortin type 3 receptors (MC3R-/-), type 4 receptors (MC4R-/-) or knockout of both (double knockout, DKO) were tested for their anorectic response to the mixed MC3/4R agonist, MTII, injected into the anterior cerebral ventricle. Wild type (WT) mice showed a strong anorexia and, as expected, DKO were completely unresponsive to MTII. In contrast, both MC3R-/- and MC4R-/- showed a partial anorectic response. Induction of c-Fos immunoreactivity by MTII was examined in brain regions including paraventricular hypothalamus (PVN) and area postrema (AP). Compared with WT, MC4R-/- showed no activation in AP but showed normal activation in PVN, whereas MC3R-/- showed reduced activation in PVN but not in AP. RT-PCR analysis showed that hypothalamic mRNA for MC3R in MC4R-/- and for MC4R in MC3R-/- was unaltered from WT levels. These data suggest that both receptor subtypes are involved in the behavioral action of MTII, and that the critical receptors are in different brain regions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800636      PMCID: PMC2967649          DOI: 10.1016/j.peptides.2010.08.016

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain.

Authors:  J Lindblom; H B Schiöth; A Larsson; J E Wikberg; L Bergström
Journal:  Brain Res       Date:  1998-11-09       Impact factor: 3.252

2.  Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

Authors:  T E Thiele; G van Dijk; K A Yagaloff; S L Fisher; M Schwartz; P Burn; R J Seeley
Journal:  Am J Physiol       Date:  1998-01

3.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

4.  Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors.

Authors:  Deniz Atalayer; Kimberly L Robertson; Carrie Haskell-Luevano; Amy Andreasen; Neil E Rowland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-07       Impact factor: 3.619

5.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.

Authors:  A S Chen; D J Marsh; M E Trumbauer; E G Frazier; X M Guan; H Yu; C I Rosenblum; A Vongs; Y Feng; L Cao; J M Metzger; A M Strack; R E Camacho; T N Mellin; C N Nunes; W Min; J Fisher; S Gopal-Truter; D E MacIntyre; H Y Chen; L H Van der Ploeg
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.

Authors:  Carrie Haskell-Luevano; Jay W Schaub; Amy Andreasen; Kim R Haskell; Marcus C Moore; Lorraine M Koerper; Francois Rouzaud; Henry V Baker; William J Millard; Glenn Walter; S A Litherland; Zhimin Xiang
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

8.  Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.

Authors:  V J Hruby; D Lu; S D Sharma; A L Castrucci; R A Kesterson; F A al-Obeidi; M E Hadley; R D Cone
Journal:  J Med Chem       Date:  1995-09-01       Impact factor: 7.446

9.  Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

Authors:  D J Marsh; G Hollopeter; D Huszar; R Laufer; K A Yagaloff; S L Fisher; P Burn; R D Palmiter
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

  9 in total
  28 in total

1.  Melanocortin 4 receptor is not required for estrogenic regulations on energy homeostasis and reproduction.

Authors:  Pingwen Xu; Liangru Zhu; Kenji Saito; Yongjie Yang; Chunmei Wang; Yanlin He; Xiaofeng Yan; Ilirjana Hyseni; Qingchun Tong; Yong Xu
Journal:  Metabolism       Date:  2016-12-13       Impact factor: 8.694

2.  Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Paula Carlson; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Genes Nutr       Date:  2014-01-24       Impact factor: 5.523

3.  Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.

Authors:  Katlyn A Fleming; Katie T Freeman; Mike D Powers; Radleigh G Santos; Ginamarie Debevec; Marc A Giulianotti; Richard A Houghten; Skye R Doering; Clemencia Pinilla; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2019-02-28       Impact factor: 7.446

4.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

5.  Profound and rapid reduction in body temperature induced by the melanocortin receptor agonists.

Authors:  Yuanzhong Xu; Eun Ran Kim; Shengjie Fan; Yan Xia; Yong Xu; Cheng Huang; Qingchun Tong
Journal:  Biochem Biophys Res Commun       Date:  2014-07-24       Impact factor: 3.575

6.  Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.

Authors:  Katlyn A Fleming; Katie T Freeman; Mark D Ericson; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2018-08-16       Impact factor: 7.446

7.  The Leptin, Dopamine and Serotonin Receptors in Hypothalamic POMC-Neurons of Normal and Obese Rodents.

Authors:  Irina V Romanova; Kira V Derkach; Anastasiya L Mikhrina; Ivan B Sukhov; Elena V Mikhailova; Alexander O Shpakov
Journal:  Neurochem Res       Date:  2018-02-03       Impact factor: 3.996

8.  Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.

Authors:  S R Ladyman; R A Augustine; E Scherf; H R Phillipps; C H Brown; D R Grattan
Journal:  J Physiol       Date:  2016-02-15       Impact factor: 5.182

9.  Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight.

Authors:  Yi Wang; Adelaide Bernard; Fanny Comblain; Xinyu Yue; Christophe Paillart; Sumei Zhang; Jeremy F Reiter; Christian Vaisse
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 10.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.